Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

XLV vs. HIAHX: which is better?

Bottom line

XLV vs HIAHX: the short answer

XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HIAHX (Hartford Healthcare Hls Fund) share a meaningful slice of their top holdings — about 72% by weight.

XLV is cheaper at 0.08% vs 0.94% — a difference of $86 a year per $10,000 invested.

Over five years, XLV returned +8.1% a year vs +3.5% for HIAHX.

Updated Nov 19, 2026

XLV vs HIAHX side by side

XLVHIAHX
TypeETFMutual fund
Fund familySPDR (State Street)Hartford
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.08%0.94%
Annual cost per $10k$8$94
10-yr cost on $10k (prospectus)$103$1,155
Max front loadNone—
12b-1 fee0.02%0%
1-yr return+14.5%+16.1%
5-yr return (annualized)+8.1%+3.5%
10-yr return (annualized)+9.8%+7.9%
Best quarter+14.5%+21.0%
Worst quarter−12.7%−15.6%
Net assets (fund)$40.6B$112.4M
Number of holdings6579
Portfolio turnover2%5%
Returns as ofDec 31, 2025Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearXLVHIAHXDifference
2025+14.5%+16.1%−1.6%
2024+2.5%+0.4%+2.1%
2023+2.0%+4.1%−2.1%
2022−2.1%−11.2%+9.2%
2021+25.9%+10.0%+15.9%
2020+13.3%+23.1%−9.8%
2019+20.7%+34.0%−13.3%
2018+6.3%−2.7%+9.0%
2017+21.7%+22.3%−0.6%
2016−2.8%−8.4%+5.6%

Source: Fund prospectus bar charts

Holdings overlap

19 of XLV's top 25 holdings also appear in HIAHX's top 25.

Shared top holdings
HoldingXLVHIAHX
Eli Lilly & Co16.51%12.47%
Johnson & Johnson10.64%6.63%
AbbVie Inc7.74%3.43%
UnitedHealth Group Inc6.57%4.72%
Merck & Co Inc5.52%6.60%
Thermo Fisher Scientific Inc3.24%1.64%
Abbott Laboratories2.75%2.10%
Intuitive Surgical Inc2.45%2.99%
CVS Health Corp2.30%2.93%
Vertex Pharmaceuticals Inc2.19%2.69%
Danaher Corp2.09%2.65%
Stryker Corp1.89%1.17%
Medtronic PLC1.75%1.02%
Elevance Health Inc1.46%2.96%
Boston Scientific Corp1.10%1.19%

Source: SEC Form N-PORT

XLV top 10

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. AbbVie Inc — 7.74%
  4. UnitedHealth Group Inc — 6.57%
  5. Merck & Co Inc — 5.52%
  6. Amgen Inc — 3.40%
  7. Thermo Fisher Scientific Inc — 3.24%
  8. Abbott Laboratories — 2.75%
  9. Gilead Sciences Inc — 2.73%
  10. Intuitive Surgical Inc — 2.45%

HIAHX top 10

  1. Eli Lilly & Co — 12.47%
  2. Johnson & Johnson — 6.63%
  3. Merck & Co Inc — 6.60%
  4. UnitedHealth Group Inc — 4.72%
  5. AbbVie Inc — 3.43%
  6. Intuitive Surgical Inc — 2.99%
  7. Elevance Health Inc — 2.96%
  8. CVS Health Corp — 2.93%
  9. Vertex Pharmaceuticals Inc — 2.69%
  10. Danaher Corp — 2.65%

FAQ

What is the difference between XLV and HIAHX?
XLV (State Street(R) Health Care Select Sector SPDR(R) ETF) and HIAHX (Hartford Healthcare Hls Fund) share a meaningful slice of their top holdings — about 72% by weight. XLV is cheaper at 0.08% vs 0.94% — a difference of $86 a year per $10,000 invested.
Which is cheaper, XLV or HIAHX?
XLV has the lower expense ratio (0.08%).
Should I own both XLV and HIAHX?
Owning both adds little diversification because their portfolios overlap heavily; most investors pick one.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.